Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity*; D002986:Clinical Trials as Topic / Q000379:methods*; D004285:Dogs; D004341:Drug Evaluation; D000882:Haplorhini; D006801:Humans; D051379:Mice; D012189:Retrospective Studies
D000970:Antineoplastic Agents